Peyona (previously Nymusa) (caffeine)
- Region
- 🇪🇺 EU
- Active substance
- caffeine
- Company
- Chiesi Farmaceutici SpA
- Status
- Authorised
- Therapeutic area
- Apnea
- CHMP opinion
- Thu 23 Apr 2009
- EU approval
- Thu 02 Jul 2009
- Application
- EMEA/H/C/001014
- ATC
- N06BC01
- Official record
- www.ema.europa.eu
Indication
Treatment of primary apnoea of premature newborns.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Gencebok Authorised · Gennisium Pharma
- 🇪🇺 Blectifor Application withdrawn · Viridian Pharma Ltd
Follow Peyona (previously Nymusa)
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.